Rejected at 12:59 a.m. Feb, 11, 2024 ] by Cameron
Author: jkerner
Related Note: 1488418305850
Rationale for change

Clozing the diseases could be helpful in memorizing their association to these specific antibodies

Rejection reason

Not needed; can add this for yourself and protect the text field

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Other::AnKing_Image::Mujeeb::Dermatomyositis_vs_polymyositis #AK_Step1_v12::#Pathoma::18_MSK::04_Skeletal_Muscle::skeletal #AK_Step1_v12::#Bootcamp::Musculoskeletal::03_Rheumatologic_Disease::07_Polymyositis_and_Dermatomyositis #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::02_Pathology::29_Polymyositis/dermatomyositis::01_Polymyositis #AK_Step2_v12::#SketchyNeurology::10_Neuromuscular_Disorders::02_Myopathy::01_Immune-Mediated_Myopathy:_Dermatomyositis/Polymyositis #AK_Step2_v12::#AMBOSS::Ro0lbS #AK_Other::AnKing_Image::!Subjects::Orthopedics_&_Rheumatology::Dermatomyositis_vs_polymyositis #PANCE::EOR::IM #AK_Step2_v12::#SketchyNeurology::10_Neuromuscular_Disorders::02_Myopathies::02_Immune-Mediated_Myopathy:_Dermatomyositis_&_Polymyositis #AK_Step3_v12::#UWorld::10150 #AK_Step1_v12::#NBME::16 #AK_Step2_v12::#AMBOSS::ow00PR #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::02_Pathology::29_Polymyositis/dermatomyositis #AK_Other::Only_Step_1&2_Overlap #AK_Step2_v12::#AMBOSS::IM0YJg #AK_Step1_v12::#OME::02_The_Cell::01_Cell_Physio::13_Myopathies #AK_Step1_v12::^Systems::Musculoskeletal::Pathology #AK_Step1_v12::#Pathoma::18_MSK::04_Skeletal_Muscle #AK_Step2_v12::#AMBOSS::Zu0Zp3 #AK_Step1_v12::#DirtyMedicine::04_Pathology::05_Autoantibodies_Rapid_Review #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::02_Pathology::29_Polymyositis/dermatomyositis::02_Dermatomyositis #AK_Step1_v12::#B&B::15_MSK::03_Pathology::07_Muscle_Disorders::Extra #AK_Step1_v12::#Bootcamp::Biochemistry::01_Cell_Biology::03_Signal_Recognition #AK_Step2_v12::#B&B::09_MSK::01_General::08_Muscle_Disorders::Extra #AK_Step1_v12::#AMBOSS::ZfaZkP #AK_Step1_v12::#OME::PreClinical::02_The_Cell::01_Cell_Physio::13_Myopathies #AK_Step2_v12::#SketchyIM::07_Rheumatology::05_Muscle_Disorders::01_Immune_Mediated_Myopathies:_Dermatomyositis_&_Polymyositis #AK_Step2_v12::#SketchyIM::07_Rheumatology::07_Systemic_Diseases::03_Scleroderma #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Musculoskeletal::Musculoskeletal_Pathology #AK_Step1_v12::#Physeo::11_Pathology::04_Musculoskeletal_Pathology::06_Skeletal_Muscle_Disorders #AK_Step1_v12::#FirstAid::02_Immunology::03_Immune_Responses::15_Autoantibodies #AK_Other::AnKing_Image::Michael #AK_Step1_v12::#SketchyPath::11_Immunology::01_Autoimmune_&_Amyloidosis::03_Polymyositis_&_Dermatomyositis #AK_Step2_v12::#SketchyIM::07_Rheumatology::06_Myofascial_Disorders::02_Polymyalgia_Rheumatica #AK_Step2_v12::#SketchyIM::07_Rheumatology::01_Approach_To_Clinical_Conditions::02_Autoantibodies_In_Rheumatic_Diseases